Tori N Yamamoto

3PUBLICATIONS
11CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 16, 2021
An engineered IL-2 partial agonist promotes CD8+ T cell stemness.

Fei Mo, Zhiya Yu, Peng Li

|Oct 09, 2019
Developing neoantigen-targeted T cell-based treatments for solid tumors.

Tori N Yamamoto, Rigel J Kishton, Nicholas P Restifo

|Aug 14, 2019
Host conditioning with IL-1β improves the antitumor function of adoptively transferred T cells.

Ping-Hsien Lee, Tori N Yamamoto, Devikala Gurusamy

Pageof 1